Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.

求助中 20 由 Aixuexi 发布于 2026/6/18 14:03:58

DOI:10.1056/NEJMoa2508668
作者：Sara M Tolaney,?Zefei Jiang,?Qingyuan Zhang,?Romualdo Barroso-Sousa,?Yeon Hee Park,?Mothaffar F Rimawi,?Cristina Saura,?Andreas Schneeweiss,?Masakazu Toi,?Yee Soo Chae,?Yasemin Kemal,?Mukesh Chaudhari
文献类型：期刊论文
补充材料：仅需补充材料

New England Journal of Medicine (NEJM)

Abstract：Background: Trastuzumab deruxtecan has shown efficacy in patients with previously treated human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer. The e

应助信息

等您来应助

上传文件

4小时前

Book学术机器人

2026/6/18 14:03:58 未找到该文献，机器人已退出，请等待人工下载

2026/6/18 14:03:58 Book学术AI机器人收到请求，开始寻找文献

2026/6/18 14:03:58 已向机器人发送请求

4小时前

Aixuexi 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierStructural characteristics of a polysaccharide from Armillariella tabescens and its protective effect on colitis mice via regulating gut microbiota and intestinal barrier function